
Pomalidomide-C2-acid
CAS No. 2225940-46-3
Pomalidomide-C2-acid( —— )
Catalog No. M28264 CAS No. 2225940-46-3
Pomalidomide-C2-acid is a PROTAC building block.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 66 | Get Quote |
![]() ![]() |
5MG | 88 | Get Quote |
![]() ![]() |
10MG | 133 | Get Quote |
![]() ![]() |
25MG | 241 | Get Quote |
![]() ![]() |
50MG | 358 | Get Quote |
![]() ![]() |
100MG | 538 | Get Quote |
![]() ![]() |
500MG | 1161 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePomalidomide-C2-acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPomalidomide-C2-acid is a PROTAC building block.
-
DescriptionPomalidomide-C2-acid is a PROTAC building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorRac1|Apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2225940-46-3
-
Formula Weight345.31
-
Molecular FormulaC16H15N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(CCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cardama GA, et al. Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells. Onco Targets Ther. 2014;7:2021‐2033. Published 2014 Oct 30.
molnova catalog



related products
-
TrxR1-IN-B19
TrxR1-IN-B19, a TrxR1 inhibitor, selectively kills gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
-
Diphenyl oxide
Used in the manufacture of spices and dyes.
-
DEPC
DEPC (Diethyl pyrocarbonate) is a potent and irreversible RNase inhibitor containing histidine residues.DEPC can be used to prevent RNA enzyme degradation by modifying histidine residues with carboxylation resulting in enzyme inactivation.